Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Assets (2016 - 2025)

Conmed (CNMD) has disclosed Non-Current Assets for 16 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 0.8% year-over-year to $1.7 billion, compared with a TTM value of $6.6 billion through Dec 2025, down 0.51%, and an annual FY2025 reading of $1.7 billion, down 0.8% over the prior year.
  • Non-Current Assets was $1.7 billion for Q4 2025 at Conmed, roughly flat from $1.7 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.7 billion in Q3 2022 and bottomed at $1.3 billion in Q1 2022.
  • Average Non-Current Assets over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2024.
  • The sharpest move saw Non-Current Assets skyrocketed 31.8% in 2023, then decreased 2.66% in 2024.
  • Year by year, Non-Current Assets stood at $1.3 billion in 2021, then skyrocketed by 31.43% to $1.7 billion in 2022, then decreased by 1.86% to $1.7 billion in 2023, then dropped by 1.08% to $1.7 billion in 2024, then decreased by 0.8% to $1.7 billion in 2025.
  • Business Quant data shows Non-Current Assets for CNMD at $1.7 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.7 billion in Q2 2025.